Bioasis Technologies Inc. (OTCMKTS:BIOAF – Get Rating) was the target of a significant increase in short interest in January. As of January 15th, there was short interest totalling 73,600 shares, an increase of 429.5% from the December 31st total of 13,900 shares. Based on an average trading volume of 124,100 shares, the short-interest ratio is presently 0.6 days.
Bioasis Technologies Price Performance
BIOAF stock traded down $0.01 during trading on Monday, hitting $0.04. 213,800 shares of the company's stock were exchanged, compared to its average volume of 66,456. The business has a 50-day moving average price of $0.08 and a two-hundred day moving average price of $0.11. Bioasis Technologies has a 52-week low of $0.02 and a 52-week high of $0.25.
Get Bioasis Technologies alerts:Bioasis Technologies (OTCMKTS:BIOAF – Get Rating) last posted its earnings results on Friday, October 28th. The company reported ($0.01) earnings per share for the quarter. The company had revenue of $0.09 million during the quarter. Equities research analysts anticipate that Bioasis Technologies will post -0.03 earnings per share for the current fiscal year.
Bioasis Technologies Company Profile
(Get Rating)Bioasis Technologies Inc, a development stage biopharmaceutical company, engages in the research and development of products for the diagnosis and treatment of neurological diseases and disorders. It is developing xB3, a platform technology for the transport of therapeutic agents across the blood-brain barrier (BBB); and the treatment of central nervous system disorders (CNS), including brain cancers, and metabolic and neurodegenerative diseases.
Featured Articles
- Get a free copy of the StockNews.com research report on Bioasis Technologies (BIOAF)
- 4 High-Yield Dividend Kings For 2023
- Will 2023 be a Good Year for Goodyear Tire Stock?
- Lululemon Stock, Buying Opportunity on Lowered Guidance?
- Is Delta On Track To Hit A Fresh 52-Week High?
- Should You Add These Warren Buffett Stocks to Your Portfolio?
Receive News & Ratings for Bioasis Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bioasis Technologies and related companies with MarketBeat.com's FREE daily email newsletter.